Literature DB >> 16246980

Thrombolytic therapy for patients with pulmonary embolism who are hemodynamically stable but have right ventricular dysfunction: pro.

Samuel Z Goldhaber1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16246980     DOI： 10.1001/archinte.165.19.2197

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  5 in total

1.  Venous thromboembolic disease.

Authors:  Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal:  J Natl Compr Canc Netw       Date:  2011-07-01       Impact factor: 11.908

2.  Initial thrombolysis treatment compared with anticoagulation for acute intermediate-risk pulmonary embolism: a meta-analysis.

Authors:  Qixia Xu; Ke Huang; Zhenguo Zhai; Yuanhua Yang; Jun Wang; Chen Wang
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

Review 3.  Evaluation of right ventricular function.

Authors:  Clifford R Greyson
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

4.  Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism.

Authors:  Damien Logeart; Lucien Lecuyer; Gabriel Thabut; Jean-Yves Tabet; Jean-Michel Tartière; Christophe Chavelas; François Bonnin; Jean-Louis Stievenart; Alain Cohen Solal
Journal:  Intensive Care Med       Date:  2006-12-13       Impact factor: 17.440

5.  Successful thrombolysis of right atrial and ventricular thrombi in a patient with massive pulmonary embolism.

Authors:  I Vogiatzis; I Dapcevic; V Sachpekidis; P Stafylas; A Sidiropoulos; S Pittas; V Tsangaris
Journal:  Hippokratia       Date:  2009-07       Impact factor: 0.471
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.